Solomon DH, Kavanaugh AJ, Schur PH, American College of Rheumatology Ad Hoc Committee on Immunologic Testing. Evidence-based guidelines for the use of immunologic tests: antinuclear antibody testing. Arthritis Rheum. 2002;47:434–44.

Article  PubMed  Google Scholar 

Bizzaro N, Wiik A. Appropriateness in anti-nuclear antibody testing: from clinical request to strategic laboratory practice. Clin Exp Rheumatol. 2004;22:349–55.

CAS  PubMed  Google Scholar 

Kavanaugh A, Tomar R, Reveille J, Solomon DH, Homburger HA. Guidelines for clinical use of the antinuclear antibody test and tests for specific autoantibodies to nuclear antigens. American College of Pathologists. Arch Pathol Lab Med. 2000;124:71–81.

Article  CAS  PubMed  Google Scholar 

Bizzaro N. Autoantibodies as predictors of disease: the clinical and experimental evidence. Autoimmun Rev. 2007;6:325–33.

Article  CAS  PubMed  Google Scholar 

Damoiseaux J, Andrade LE, Fritzler MJ, Shoenfeld Y. Autoantibodies 2015: from diagnostic biomarkers toward prediction, prognosis and prevention. Autoimmun Rev. 2015;14:555–63.

Article  CAS  PubMed  Google Scholar 

Mahler M, Fritzler MJ. Epitope specificity and significance in systemic autoimmune diseases. Ann N Y Acad Sci. 2010;1183:267–87.

Article  CAS  PubMed  Google Scholar 

Carbone T, Pafundi V, Tramontano G, Gilio M, Padula MC, Padula AA, D’Angelo S. Prevalence and serological profile of anti-DFS70 positive subjects from a routine ANA cohort. Sci Rep. 2019;9(1):2177.

Article  PubMed  PubMed Central  Google Scholar 

Wiik AS. Anti-nuclear autoantibodies: clinical utility for diagnosis, prognosis, monitoring, and planning of treatment strategy in systemic immunoinflammatory diseases. Scand J Rheumatol. 2005;34:260–8.

Article  CAS  PubMed  Google Scholar 

Agmon-Levin N, Damoiseaux J, Kallenberg C, Sack U, Witte T, Herold M, Bossuyt X, Musset L, Cervera R, Plaza-Lopez A, Dias C, Sousa MJ, Radice A, Eriksson C, Hultgren O, Viander M, Khamashta M, Regenass S, Andrade LE, Wiik A, Tincani A, Rönnelid J, Bloch DB, Fritzler MJ, Chan EK, Garcia-De La Torre I, Konstantinov KN, Lahita R, Wilson M, Vainio O, Fabien N, Sinico RA, Meroni P, Shoenfeld Y. International recommendations for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies. Ann Rheum Dis. 2014;73(1):17–23.

Meroni PL, Schur PH. ANA screening: an old test with new recommendations. Ann Rheum Dis. 2010;69(8):1420–2.

Article  CAS  PubMed  Google Scholar 

Hiemann R, Bu¨ttner T, Krieger T, Roggenbuck D, Sack U, Conrad K. Challenges of 417 automated screening and differentiation of non-organ specific autoantibodies 418 on HEp-2 cells. Autoimmun Rev. 2009;9:17–22.

Article  CAS  PubMed  Google Scholar 

Bizzaro N, Tozzoli R, Tonutti E, Piazza A, Manoni F, Ghirardello A, et al. Variability between methods to determine ANA, antidsDNA and anti-ENA autoantibodies: a collaborative study with the biomedical industry. J Immunol Methods. 1998;219:99–107.

Article  CAS  PubMed  Google Scholar 

Song L, Hennink EJ, Young IT, Tanke HJ. Photobleaching kinetics of fluorescein in quantitative fluorescence microscopy. Biophys J. 1995;68:2588–600.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wiik AS, Bizzaro N. Missing links in high quality diagnostics of inflammatory systemic rheumatic diseases: it is all about the patient! Auto Immun Highlights. 2012;3(2):35–49.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fritzler MJ. The antinuclear antibody test: last or lasting gasp? Arthritis Rheum. 2011;63(1):19–22.

Article  PubMed  Google Scholar 

Rigon A, Infantino M, Merone M, Iannello G, Tincani A, Cavazzana I, et al. The inter-observer reading variability in anti-nuclear antibodies indirect (ANA) immunofluorescence test: a multicenter evaluation and a review of the literature. Autoimmun Rev. 2017;16:1224–9.

Article  CAS  PubMed  Google Scholar 

Copple SS, Giles SR, Jaskowski TD, Gardiner AE, Wilson AM, Hill HR. Screening for IgG antinuclear autoantibodies by HEp-2 indirect fluorescent antibody assays and the need for standardization. Am J Clin Pathol. 2012;137:825–30.

Article  PubMed  Google Scholar 

Infantino M, Meacci F, Grossi V, Manfredi M, Benucci M, Merone M, et al. The burden of the variability introduced by the HEp-2 assay kit and the CAD system in ANA indirect immunofluorescence test. Immunol Res. 2017;65:345–54.

Article  CAS  PubMed  Google Scholar 

Mahler M, Meroni PL, Bossuyt X, Fritzler MJ. Current concepts and future directions for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies. J Immunol Res. 2014;2014:315179.

Article  PubMed  PubMed Central  Google Scholar 

Tozzoli R, Antico A, Porcelli B, Bassetti D. Automation in indirect immunofluorescence testing: a new step in the evolution of the autoimmunology laboratory. Auto Immun Highlights. 2012;13(3):59–65.

Article  Google Scholar 

Bizzaro N, Antico A, Platzgummer S, Tonutti E, Bassetti D, Pesente F, Tozzoli R, Tampoia M, Villalta D, Study Group on Autoimmune Diseases of the Italian Society of Laboratory Medicine, Italy. Automated antinuclear immunofluorescence antibody screening: a comparative study of six computer-aided diagnostic systems. Autoimmun Rev. 2014;13:292–8.

Article  CAS  PubMed  Google Scholar 

van Beers JJBC, Hahn M, Fraune J, Mallet K, Krause C, Hormann W, Fechner K, Damoiseaux JGMC. Performance analysis of automated evaluation of antinuclear antibody indirect immunofluorescent tests in a routine setting. Auto Immun Highlights. 2018;9:8.

Article  PubMed  PubMed Central  Google Scholar 

Copple SS, Jaskowski TD, Giles R, Hill HR. Interpretation of ANA indirect immunofluorescence test outside the darkroom using NOVA view compared to manual microscopy. J Immunol Res. 2014;2014:149316.

Article  PubMed  PubMed Central  Google Scholar 

Krause C, Ens K, Fechner K, Voigt J, Fraune J, Rohwäder E, Hahn M, Danckwardt M, Feirer C, Barth E, Martinetz T, Stöcker W. EUROPattern Suite technology for computer-aided immunofluorescence microscopy in autoantibody diagnostics. Lupus. 2015;24:516–29.

Article  CAS  PubMed  Google Scholar 

Van Hoovels L, Schouwers S, Van den Bremt S, Bogaert L, Vandeputte N, Vercammen M, Bossuyt X. Analytical performance of the single well titer function of NOVA View®: good enough to omit ANA IIF titer analysis? Clin Chem Lab Med. 2018;56:258–61.

Article  PubMed  Google Scholar 

Meroni PL, Bizzaro N, Cavazzana I, Borghi MO, Tincani A. Automated tests of ANA immunofluorescence as throughput autoantibody detection technology: strengths and limitations. BMC Med. 2014;3(12):38.

Article  Google Scholar 

Cinquanta L, Bizzaro N, Pesce G. Standardization and quality assessment under the perspective of automated computer-assisted HEp-2 immunofluorescence assay systems. Front Immunol. 2021;25(12):638863.

Article  Google Scholar 

Van Hoovels L, Bossuyt X, Manfredi M, Grossi V, Benucci M, Van Den Bremt S, De Baere H, Franceschi D, Tosi E, Meoni M, Bizzaro N, Infantino M. Integrating quality assurance in autoimmunity: the changing face of the automated ANA IIF test. Clin Chem Lab Med. 2021;59:1247–55.

Article  PubMed  Google Scholar 

Chan EK, Damoiseaux J, Carballo OG, Conrad K, de Melo Cruvinel W, Francescantonio PL, Fritzler MJ, Garcia-De La Torre I, Herold M, Mimori T, Satoh M, von Mühlen CA, Andrade LE. Report of the first international consensus on standardized nomenclature of antinuclear antibody HEp-2 cell patterns 2014–2015. Front Immunol. 2015;6:412.

Chan EK, Damoiseaux J, de Melo Cruvinel W, Carballo OG, Conrad K, Francescantonio PL, Fritzler MJ, Garcia-De La Torre I, Herold M, Mimori T, Satoh M, Mühlen CA von, Andrade LE. Report on the second international consensus on ANA pattern (ICAP) workshop in Dresden 2015. Lupus. 2016;25:797–804.

Andrade LEC, Klotz W, Herold M, Conrad K, Rönnelid J, Fritzler MJ, von Mühlen CA, Satoh M, Damoiseaux J, de MeloCruvinel W, Chan EKL, Executive Committee of ICAP. International consensus on antinuclear antibody patterns: definition of the AC-29 pattern associated with antibodies to DNA topoisomerase I. Clin Chem Lab Med. 2018;56:1783–8.

Article  CAS  PubMed  Google Scholar 

Herold M, Klotz W, Andrade LEC, Conrad K, de Melo CW, Damoiseaux J, Fritzler MJ, von Muhlen CA, Satoh M, Chan EKL. International consensus on antinuclear antibody patterns: defining negative results and reporting unidentified patterns. Clin Chem Lab Med. 2018;56:1799–802.

Article  CAS  PubMed  Google Scholar 

Oyaert M, Bossuyt X, Ravelingien I, Van Hoovels L. Added value of indirect immunofluorescence intensity of automated antinuclear antibody testing in a secondary hospital setting. Clin Chem Lab Med. 2016;54:e63–6.

Article  CAS  PubMed  Google Scholar 

Vulsteke JB, Van Hoovels L, Willems P, Vander Cruyssen B, Vanderschueren S, Westhovens R, Blockmans D, De Langhe E, Bossuyt X. Titre-specific positive predictive value of antinuclear antibody patterns. Ann Rheum Dis. 2021;80:e128.

Article  PubMed  Google Scholar 

Schouwers S, Bonnet M, Verschueren P, Westhovens R, Blockmans D, Mariën G, Bossuyt X. Value-added reporting of antinuclear antibody testing by automated indirect immunofluorescence analysis. Clin Chem Lab Med. 2014;52(4):547–51.

Article  CAS  PubMed  Google Scholar 

Fierz W, Bossuyt X. Likelihood ratio approach and clinical interpretation of laboratory tests. Front Immunol. 2021;16(12):655262.

Article  Google Scholar 

Bizzaro N, Bossuyt X, Haapala AM, Shoenfeld Y, Sack U. Accreditation in autoimmune diagnostic laboratories. A position paper of the European Autoimmunity Standardisation Initiative (EASI). Autoimmun Rev. 2017;16:81–6.

Article  PubMed  Google Scholar 

ISO 15189:2012. Medical laboratories — requirements for quality and competence. Geneva: ISO; 2012.

Sack U, Bossuyt X, Andreeva H, Antal-Szalmás P, Bizzaro N, Bogdanos D, European Autoimmunity Standardisation Initiative, et al. Quality and best practice in medical laboratories: specific requests for autoimmunity testing. Auto Immun Highlights. 2020;11:12.

Article  PubMed  PubMed Central  Google Scholar 

Bogaert L, Van den Bremt S, Schouwers S, Bossuyt X, Van Hoovels L. Harmonizing by reducing inter-run variability: performance evaluation of a quality assurance program for antinuclear antibody detection by indirect immunofluorescence. Clin Chem Lab Med. 2019;57:990–8.